The clinician who evaluates you through Novi will make a prescription recommendation based on your actual health history
Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dualacting medication that targets both GLP1 and glucosedependent insulinotropic polypeptide (GIP) receptors, which may enhance its effects on appetite regulation and metabolism
Your healthcare provider should guide you through this dosing process
Still, the connection has generated growing interest among researchers and clinicians, particularly as more people taking GLP-1 medications report changes in cravings and reward-related behaviors
Il tessuto adiposo viscerale, infatti, svolge un ruolo centrale: in condizioni di obesit assume caratteristiche immunometaboliche, con infiltrazione macrofagica e polarizzazione pro-infiammatoria (M1), favorendo la resistenza insulinica [3]